CENTER FOR BIOMEDICAL RESEARCH AND DEVELOPMENT, NCKU
Area: Incubation
Booth No: N516
Website: https://cbmrd.web2.ncku.edu.tw/
Exhibitor Profile
Five innovative products. 1. Anti-platelet drug (RR) with a low risk of bleeding and thrombocytopenia. 2. Bispecific thrombolytic drug (tPA-RR) inhibits thrombosis while maintaining hemostasis. 3. Bispecific anti-cancer drug effectively suppresses the growth of glioblastoma. 4. Bispecific anti-fibrotic drug significantly inhibits the expression of vital fibrotic genes. 5. High stability and high activity of IL-2 for T cell, NK cell, and stem cell cultures.
Brands
CENTER FOR BIOMEDICAL RESEARCH AND DEVELOPMENT, NCKU
Video
Exhibit Products
-
Antithrombotic Drug with Low Risk of Bleeding
-
Anti-fibrotic Drug Targeting ECM
-
Modification Platforms for Protein Therapeutics
-
Fibrin and Platelet-targeting Thrombolytic Drug
-
Bispecific Drugs for Cancers
-
Protein Production and GLP Laboratory
Exhibitor Press Release
Exhibitors you may be interested in
Highest Rated